Page last updated: 2024-12-06

4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate: potently inhibits trypsin, plasmin and thrombin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65921
CHEMBL ID2105433
SCHEMBL ID2109248
MeSH IDM0159857

Synonyms (18)

Synonym
e3123
patamostat
p-((2-succinimidoethyl)thio)phenyl p-guanidinobenzoate
benzoic acid, 4-((aminoiminomethyl)amino)-, 4-((2-(2,5-dioxo-1-pyrrolidinyl)ethyl)thio)phenyl ester
4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate
patamostat [inn]
[4-[2-(2,5-dioxopyrrolidin-1-yl)ethylsulfanyl]phenyl] 4-(diaminomethylideneamino)benzoate
114568-26-2
unii-2t7w4ea51w
2t7w4ea51w ,
CHEMBL2105433
SCHEMBL2109248
4-((2-(2,5-dioxopyrrolidin-1-yl)ethyl)thio)phenyl 4-guanidinobenzoate
DTXSID90150785
Q27255575
MS-27122
CS-0064977
HY-114080

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"This study was designed to evaluate the acute toxic effects of cyclosporin A on the exocrine pancreas and the protective effects of a new potent protease inhibitor, 4-(2-succinimidoethylthio) phenyl 4-guanidinobenzoate methanesulfonate, E3123."( Acute cytotoxic effect of cyclosporin A on pancreatic acinar cells in rats. Protective effect of the synthetic protease inhibitor E3123.
Ando, K; Hirano, T; Manabe, T; Tobe, T, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (16.67)18.7374
1990's15 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.90 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]